These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 16817875)

  • 1. Prominent corticosteroid disturbance in experimental prion disease.
    Voigtländer T; Unterberger U; Touma C; Palme R; Polster B; Strohschneider M; Dorner S; Budka H
    Eur J Neurosci; 2006 May; 23(10):2723-30. PubMed ID: 16817875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bax deletion does not protect neurons from BSE-induced death.
    Coulpier M; Messiaen S; Hamel R; Fernández de Marco M; Lilin T; Eloit M
    Neurobiol Dis; 2006 Sep; 23(3):603-11. PubMed ID: 16854590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral stress accelerates plaque pathogenesis in the brain of Tg2576 mice via generation of metabolic oxidative stress.
    Lee KW; Kim JB; Seo JS; Kim TK; Im JY; Baek IS; Kim KS; Lee JK; Han PL
    J Neurochem; 2009 Jan; 108(1):165-75. PubMed ID: 19012747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induced neuroprotection independently from PrPSc accumulation in a mouse model for prion disease treated with simvastatin.
    Haviv Y; Avrahami D; Ovadia H; Ben-Hur T; Gabizon R; Sharon R
    Arch Neurol; 2008 Jun; 65(6):762-75. PubMed ID: 18541796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overactivation of calcineurin induced by amyloid-beta and prion proteins.
    Agostinho P; Lopes JP; Velez Z; Oliveira CR
    Neurochem Int; 2008 May; 52(6):1226-33. PubMed ID: 18295934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
    Sas K; Robotka H; Toldi J; Vécsei L
    J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PrPSc level and incubation time in a transgenic mouse model expressing Borna disease virus phosphoprotein after intracerebral prion infection.
    Sakudo A; Onodera T; Ikuta K
    Neurosci Lett; 2008 Jan; 431(1):81-5. PubMed ID: 18155836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell models of prion infection.
    Vilette D
    Vet Res; 2008; 39(4):10. PubMed ID: 18073097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice.
    Pfeifer A; Eigenbrod S; Al-Khadra S; Hofmann A; Mitteregger G; Moser M; Bertsch U; Kretzschmar H
    J Clin Invest; 2006 Dec; 116(12):3204-10. PubMed ID: 17143329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An endoplasmic-reticulum-specific apoptotic pathway is involved in prion and amyloid-beta peptides neurotoxicity.
    Ferreiro E; Resende R; Costa R; Oliveira CR; Pereira CM
    Neurobiol Dis; 2006 Sep; 23(3):669-78. PubMed ID: 16844381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of parvalbumin and calbindin D28k in experimental scrapie.
    Voigtländer T; Unterberger U; Guentchev M; Schwaller B; Celio MR; Meyer M; Budka H
    Neuropathol Appl Neurobiol; 2008 Aug; 34(4):435-45. PubMed ID: 18005331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of glial cell line-derived neurotrophic factor (GDNF) in the brains of scrapie-infected mice.
    Lee YJ; Jin JK; Jeong BH; Carp RI; Kim YS
    Neurosci Lett; 2006 Dec; 410(3):178-82. PubMed ID: 17101222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prion disease causes less severe lesions in human hippocampus than other parts of brain.
    Kaneko M; Sugiyama N; Sasayama D; Yamaoka K; Miyakawa T; Arima K; Tsuchiya K; Hasegawa K; Washizuka S; Hanihara T; Amano N; Yagishita S
    Psychiatry Clin Neurosci; 2008 Jun; 62(3):264-70. PubMed ID: 18588585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. beta-Amyloid deposition and prion infection in adult primary brain cell long-term culture model.
    Yun SW; Kouznetsova E; Nitschke C; Heinitz K; Schliebs R; Gerlach M; Riederer P; Klein MA
    Biochem Biophys Res Commun; 2007 Aug; 360(3):520-4. PubMed ID: 17612503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgenic mouse models of prion diseases.
    Telling GC
    Methods Mol Biol; 2008; 459():249-63. PubMed ID: 18576160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rodent models for prion diseases.
    Groschup MH; Buschmann A
    Vet Res; 2008; 39(4):32. PubMed ID: 18284909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A manganese-superoxide dismutase/catalase mimetic extends survival in a mouse model of human prion disease.
    Brazier MW; Doctrow SR; Masters CL; Collins SJ
    Free Radic Biol Med; 2008 Jul; 45(2):184-92. PubMed ID: 18455516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Copper deficiency elicits glial and neuronal response typical of neurodegenerative disorders.
    Zucconi GG; Cipriani S; Scattoni R; Balgkouranidou I; Hawkins DP; Ragnarsdottir KV
    Neuropathol Appl Neurobiol; 2007 Apr; 33(2):212-25. PubMed ID: 17359362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-beta1 is increased in a transgenic mouse model of familial Alzheimer's disease and causes neuronal apoptosis.
    Salins P; He Y; Olson K; Glazner G; Kashour T; Amara F
    Neurosci Lett; 2008 Jan; 430(1):81-6. PubMed ID: 18063474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine A1 receptor protein levels and activity is increased in the cerebral cortex in Creutzfeldt-Jakob disease and in bovine spongiform encephalopathy-infected bovine-PrP mice.
    Rodríguez A; Martín M; Albasanz JL; Barrachina M; Espinosa JC; Torres JM; Ferrer I
    J Neuropathol Exp Neurol; 2006 Oct; 65(10):964-75. PubMed ID: 17021401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.